David Toung
Stock Analyst at Argus Research
(4.35)
# 285
Out of 4,827 analysts
120
Total ratings
64.52%
Success rate
10.51%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Maintains: Buy | $620 → $470 | $410.78 | +14.42% | 7 | Apr 29, 2025 | |
| UNH UnitedHealth Group | Downgrades: Hold | n/a | $385.55 | - | 8 | Apr 21, 2025 | |
| IART Integra LifeSciences Holdings | Upgrades: Buy | n/a | $12.89 | - | 2 | Mar 31, 2025 | |
| ELV Elevance Health | Reiterates: Hold | $405 | $412.38 | -1.69% | 1 | Jan 29, 2025 | |
| ABBV AbbVie | Upgrades: Buy | n/a | $185.58 | - | 6 | Nov 4, 2024 | |
| CAH Cardinal Health | Maintains: Buy | $115 → $125 | $147.27 | -15.12% | 9 | Sep 11, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Hold | n/a | $141.36 | - | 5 | Jun 28, 2024 | |
| AMGN Amgen | Maintains: Buy | $300 → $340 | $272.05 | +24.98% | 10 | Jun 27, 2024 | |
| MCK McKesson | Maintains: Buy | $570 → $670 | $690.25 | -2.93% | 6 | Jun 24, 2024 | |
| ZBH Zimmer Biomet Holdings | Upgrades: Buy | $150 | $95.11 | +57.71% | 7 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $770 → $840 | $751.45 | +11.78% | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $95 | $56.18 | +69.10% | 1 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $70.50 | +56.03% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $248.76 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $22.97 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $253.35 | - | 8 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $382.46 | -18.95% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $353.92 | -12.41% | 2 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $538.16 | -40.54% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $134.00 | +0.75% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $98.16 | -23.59% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $46.88 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $77.65 | +41.66% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $83.62 | +97.32% | 6 | Aug 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.08 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $123 | $49.78 | +146.08% | 3 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $67.30 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $110.13 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $155.66 | -0.42% | 4 | Mar 27, 2020 |
Thermo Fisher Scientific
Apr 29, 2025
Maintains: Buy
Price Target: $620 → $470
Current: $410.78
Upside: +14.42%
UnitedHealth Group
Apr 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $385.55
Upside: -
Integra LifeSciences Holdings
Mar 31, 2025
Upgrades: Buy
Price Target: n/a
Current: $12.89
Upside: -
Elevance Health
Jan 29, 2025
Reiterates: Hold
Price Target: $405
Current: $412.38
Upside: -1.69%
AbbVie
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $185.58
Upside: -
Cardinal Health
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $147.27
Upside: -15.12%
Charles River Laboratories International
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $141.36
Upside: -
Amgen
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $272.05
Upside: +24.98%
McKesson
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $690.25
Upside: -2.93%
Zimmer Biomet Holdings
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $95.11
Upside: +57.71%
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $751.45
Upside: +11.78%
May 9, 2024
Maintains: Buy
Price Target: $89 → $95
Current: $56.18
Upside: +69.10%
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $70.50
Upside: +56.03%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $248.76
Upside: -
Mar 22, 2024
Downgrades: Hold
Price Target: n/a
Current: $22.97
Upside: -
Mar 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $253.35
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $382.46
Upside: -18.95%
May 10, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $353.92
Upside: -12.41%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $538.16
Upside: -40.54%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $134.00
Upside: +0.75%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $98.16
Upside: -23.59%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $46.88
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $77.65
Upside: +41.66%
Aug 27, 2021
Maintains: Buy
Price Target: $150 → $165
Current: $83.62
Upside: +97.32%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $7.08
Upside: -
Jun 18, 2021
Maintains: Buy
Price Target: $110 → $123
Current: $49.78
Upside: +146.08%
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $67.30
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $110.13
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $155.66
Upside: -0.42%